DURHAM, N.C. March 20, 2017 – Patients undergoing cardiac surgery that requires use of a heart-lung machine can see complications afterwards. Some experience low cardiac output syndrome (LCOS), in which their heart is unable to pump enough blood to properly supply their organs, making them susceptible to heart attack, death and other risks. A study […]
Study is a first step in potentially expanding post-ACS treatment DURHAM, N.C. March 20, 2017 – Substituting rivaroxaban for aspirin in patients with acute coronary syndromes (ACS) appears to cause no significant increase in bleeding risk, according to a study led by scientists from the Duke Clinical Research Institute (DCRI) and Harvard Medical School. The […]
Presented at ACC and published in Journal of American College of Cardiology, the CardioMEMS™ HF System offers sustained benefits for patients suffering from symptomatic heart failure Heart failure hospitalizations cut nearly in half and an average reduction of $10,500 in comprehensive health care costs six months following implant WASHINGTON, March 19, 2017 /PRNewswire/ — New […]
92.8% procedural success observed in reducing leaky heart valve 80.0% of those treated free from repeat heart failure re-hospitalization 85.9% of patients were discharged to home after two-day average hospital stay WASHINGTON, March 18, 2017 /PRNewswire/ — Abbott (NYSE: ABT) today announced favorable one-year outcomes from the largest study of real-world experience for the MitraClip […]
Results emphasize importance of proper vessel sizing and following current instructions for use for optimal clinical outcomes WASHINGTON, March 18, 2017 — Abbott today announced that data from the ABSORB III U.S. pivotal trial showed that Absorb, Abbott’s first-of-its-kind dissolving stent, had comparable efficacy and safety results to XIENCE, Abbott’s leading metallic drug-eluting stent, between […]
EMPEROR HF clinical trial program will evaluate the efficacy and safety of empagliflozin in patients with chronic heart failure, including those with and without type 2 diabetes Heart failure affects 26 million people worldwide, and 5.7 million people in the U.S., and is associated with high morbidity and mortality EMPEROR HF will include approximately 7,000 […]
DURHAM, N.C. March 16, 2017 – Richard Bedlack, M.D., Ph.D., is known for wearing outrageous outfits to lift patients’ spirits in his work as director of the Duke ALS Clinic. Fashion designer Paul Smith heard about this, and recently sent seven rare ties for Duke men’s basketball staff and supporters to wear in the March […]
Anticoagulants were not used according to guidelines, despite evidence they prevent strokes DURHAM, N.C. March 15, 2017 – More than 80 percent of stroke patients with a history of atrial fibrillation either received not enough or no anticoagulation therapy prior to having a stroke, despite the drugs’ proven record of reducing stroke risk, according to […]
The findings advance progress toward HIV vaccine design DURHAM, N.C. March 15, 2017 – A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination. “A goal for an HIV-1 vaccine is to induce […]
A shorter regimen is scientifically sound, but most women still get the longer therapy DURHAM, N.C. March 14, 2017 – More than half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study led by Duke […]